Results 171 to 180 of about 22,142 (188)

Ibrutinib

Reactions Weekly, 2016
  +4 more sources

Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase

Circulation, 2020
Javid J. Moslehi, Bénédicte Lebrun-Vignes, Joe-Elie Salem   +2 more
exaly  

Ibrutinib

Reactions Weekly, 2020
openaire   +2 more sources

Ibrutinib Is Associated With Increased Cardiovascular Events and Major Bleeding in Older CLL Patients

JACC: CardioOncology, 2023
Wyatt P Bensken, Weichuan Dong, Akiva Diamond   +2 more
exaly  

Ibrutinib modulates Aβ/tau pathology, neuroinflammation, and cognitive function in mouse models of Alzheimer's disease

Aging Cell, 2021
Hyang-Sook Hoe, Minseok Song, Kyoungho Suk   +2 more
exaly  

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Cancer Cell, 2017
Craig J. Thomas, John A. Butman, Louis M Staudt   +2 more
exaly  

Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients

Annals of Oncology, 2017
Jeffrey Pu, Nicole Lamanna, P M Barr
exaly  

Cardiovascular Toxicities Associated With Ibrutinib

Journal of the American College of Cardiology, 2019
Javid J. Moslehi, Bénédicte Lebrun-Vignes, Joe-Elie Salem   +2 more
exaly  

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Annals of Oncology, 2015
Chan Yoon Cheah, Dai Chihara, Nathan H Fowler   +2 more
exaly  

Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study Free

Blood, 2019
M Lia Palomba, Steven P. Treon, Dipti Talaulikar   +2 more
exaly